Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander), By Shape (Round, Anatomical), By End-use (Hospitals, Cosmetology Clinics), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global breast reconstruction market size was valued at USD 465.3 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The growth can be accredited to the increasing number of breast cancer patients and the availability of favorable reimbursement policies. Moreover, an increase in the number of breast reconstruction procedures, along with technological advancements, is expected to impel the market growth.

There has been an increase in the number of breast cancer patients globally. For instance, according to the WHO, around 2.3 million women globally were diagnosed with breast cancer in the year 2020. Furthermore, as per a similar source, as of 2020, more than 7.8 million new breast cancer cases were diagnosed since 2015. Additionally, as per Cancer Research U.K., approximately 55,900 breast cancer patients are diagnosed annually in the U.K. alone. Moreover, according to a similar source, breast cancer is the most common type of cancer in the U.K.

Similarly, as per Breast Cancer Now, one in every seven women in the U.K. are expected to be diagnosed with breast cancer. Thus, as a result of the increase in the number of people suffering from breast cancer, the demand for breast reconstruction is expected to increase, thereby impelling the market growth over the forecast period. 

In addition, reimbursement for breast reconstruction is being made available in some countries, which is further increasing the demand for breast reconstruction. For instance, as per a study by ScienceDirect, the mean reimbursement rate for pedicled flaps was calculated to be USD 5,993.16, whereas the similar for free flaps was USD 4,325.84. Moreover, as per a similar source, the reimbursement for breast reconstructions across European countries was similarly based on the procedure.

Similarly, according to Medicare, breast reconstruction can be reimbursed if the person has gone under breast mastectomy as a result of breast cancer. Additionally, as per Services Australia, the external breast prosthesis reimbursement program can reimburse the breast prosthesis after breast cancer. Thus, due to the aforementioned factors, the market is anticipated to witness growth during the forecast period.

An increasing number of breast reconstruction procedures is further anticipated to fuel the growth of the market. For instance, as per the NCBI, the rate of breast reconstruction post-mastectomy increased from 19.4% in the year 2015 to 53.4% in 2018. Moreover, according to the American Society of Plastic Surgeons, the number of breast reconstruction procedures increased from 78,882 in 2000 to 137,808 in 2020, thereby propelling the market growth.

The COVID-19 pandemic was anticipated to restrict the growth of the market to a certain extent as the number of elective surgeries was postponed. However, with ease in restrictions, the earlier postponed elective surgeries are expected to take place in the post-pandemic period, which may help the market regain its market share. Moreover, to cope with the increasing demand, the market players are entering into various strategic initiatives such as product launches, awareness campaigns, and geographic expansion. For instance, in October 2021, Sientra, Inc. along with Mission Plasticos launched a philanthropic initiative, ‘Reshaping Lives: Full Circle’ for women living in poverty in America. This was aimed at providing women living in poverty with breast reconstruction post-mastectomy.

Product Insights

Implants held the largest revenue share of over 60.0% in 2021. This can be attributed to the rising use of breast implants during breast augmentation surgeries. For instance, according to the NCBI, around 8.08 women per 1,000 in the U.S. has one or other kind of breast implant. Moreover, as per the University of Utah Health, around 35 million women have implanted textured breast implants, whereas, as per a similar source, it is believed that more than 1.5 million women are implanted every year. Thus, as a result, the implant segment is anticipated to dominate the market in the years to come.

The tissue expander segment is projected to register the fastest growth rate of 8.7% over the forecast period. The growth can be accredited to the increasing use of tissue expanders for breast reconstruction. For instance, according to a report by Science Direct, tissue expander reconstruction accounted for up to 65% of the total breast reconstruction performed. Moreover, as per Medscape, with 101,657 breast reconstruction surgeries performed in the U.S. in 2018, 69% included tissue expanders and implants. Additionally, breast reconstruction with the use of tissue expanders is faster, simpler, and relatively cheaper. Furthermore, it is compatible for each and every type of woman, unlike the tissue reconstruction process, where tummy muscle or tissue is necessary to carry out the procedure, thus impelling the segment growth.

Shape Insights

Round shape held the largest revenue share of over 55.0% in 2021. The dominance can be accredited to the rising number of product launches, regular updates by the FDA on breast implant safety, and the conduction of various clinical trials. For instance, in May 2021, GC Aesthetics launched its next-generation round silicone breast implant PERLE. Moreover, in October 2021, the U.S. FDA updated its safety requirements for breast implants and restricted the sales and distribution of breast implants to ensure that patients undergoing breast implant surgery have adequate information. Thus, due to the above-mentioned factors, round-shaped breast implants are expected to witness significant growth.

The anatomical shape is projected to register the fastest CAGR of 8.7% during the forecast period. The growth can be credited to several advantages of anatomical-shaped breast implants. For instance, according to Sayah Institute, these breast implants provide a natural shape and textured surface, thus the implant does not shift after placement. Moreover, their texture makes them ideal for breast augmentation in women with little natural breast tissue, thus impelling the segment growth.

End-use Insights

The hospitals segment held the largest revenue share of over 45.0% in 2021. The dominance of the segment can be attributed to a rise in the number of hospitals worldwide. For instance, according to the Athar Institute of Health Management & Studies, the hospitals in India makeup 80% of the total healthcare market. Moreover, as per The Canadian Encyclopedia, there are 706 public and 193 private hospitals in Canada. Additionally, there has been an increase in medical tourism globally. An increase in medical tourism is expected to increase the quality of healthcare facilities provided by the hospitals. Thus, due to the aforementioned factors, the hospitals segment is anticipated to register a significant growth rate over the forecast period.

The ambulatory surgical centers are projected to register the fastest growth rate of 8.7% over the forecast period. The growth can be attributed to the global increase in the number of breast reconstruction surgeries in the ASCs. For instance, as per the Plastic Surgery Statistics Report, around 1,692,717 breast reconstruction surgeries were performed in the ASCs. Moreover, as per a similar report, the percentage change from 2019 to 2020 was around a 7% increase in 2020. Thus, as a result of the above-mentioned factor, the segment is anticipated to register a significant growth rate over the forecast period.  

Regional Insights

North America captured the largest revenue share of over 40.0% in 2021. This can be credited to the number of breast cancer patients in this region. For instance, as per the Canadian Cancer Society, approximately 78 Canadian women are diagnosed with breast cancer every day, whereas, 15 women die of breast cancer every day. Moreover, as per a similar source, 28,600 Canadian women are predicted to be diagnosed with breast cancer in the year 2022. This number represents 25% of the new cases of cancer overall. Therefore, the above-mentioned factors are expected to boost the market growth in the North American region.

The Asia Pacific region is expected to register the fastest CAGR of 7.1% over the forecast period. The growth can be attributed to the rapidly increasing breast cancer population and a rise in awareness regarding the availability of breast reconstruction surgeries. For instance, according to the data made available by the NCBI, around 70,400 deaths and 303,600 new cases of breast cancer were detected in China. Moreover, as per a similar source, with the changing demographics and risks in China, the incidence rate and mortality rate are expected to increase by 2030. Moreover, as per a study by a similar source, more than 76.5% of women preferred breast reconstruction after mastectomy. Hence, the market is projected to witness significant growth during the forecast period.

Key Companies & Market Share Insights

Key players are involved in adopting strategies such as geographic expansion, mergers and acquisitions, partnerships, and launching new products to strengthen their foothold in the market. For instance, in May 2020, POLYTECH Health & Aesthetics GmbH announced the expansion of its manufacturing facility and headquarters. The expansion of manufacturing is aimed to increase production and supply, thereby increasing the market share of the company. Key players are significantly investing in research and development to manufacture technologically advanced products. Some prominent players in the global breast reconstruction market include:

• Johnson & Johnson

• Allergan Inc.

• Sientra Inc.

• Ideal Implant Incorporated

• Establishment Labs S.A.

• POLYTECH Health & Aesthetics GmbH

• RTI Surgical Holdings

• Sebbin

• Integra LifeSciences

• GC Aesthetics

Breast Reconstruction Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global breast reconstruction market report based on product, shape, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Implants

    • Silicone Breast Implants

    • Saline Breast Implants

  • Tissue Expander

    • Saline Expander

    • Air Tissue Expander

  • Acellular Dermal Matrix

• Shape Outlook (Revenue, USD Million, 2018 - 2030)

  • Round Shape

  • Anatomical Shape

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Cosmetology Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE